NCT03842917View on ClinicalTrials.gov

SAlt Diet and Various Biomarkers Effects on Blood Pressure and Proteinuria During Inhibition of VEGF)

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

April 26, 2019

Primary Completion Date

April 27, 2022

Study Completion Date

June 15, 2022

Conditions
Patient Starting BevacizumabCancer
Interventions
OTHER

Biological samples

Urine and blood samples

OTHER

Blood pressure measurement

Home blood pressure self-measurement and hospital blood pressure measurement

Trial Locations (3)

37044

Medical Oncology Service, University Hospital, Tours, Tours

Oncological Gastroenterology Service, University Hospital, Tours, Tours

Pneumology, University Hospital, Tours, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT03842917 - SAlt Diet and Various Biomarkers Effects on Blood Pressure and Proteinuria During Inhibition of VEGF) | Biotech Hunter | Biotech Hunter